AKT1 and ovarian cancer: Verbascoside (VB), a phenylpropanoid glycoside, demonstrates significant anti-tumor activity against ovarian cancer (OC) by facilitating M1 macrophage polarization through the CCN1-AKT/NF-κB signaling pathway.